GRFS Stock Financial Analysis - Grifols, S.A. - Depositary Receipt (Common Stock) (NasdaqGS) Stock

Overview

Grifols, S.A. is a global healthcare company operating in the biotechnology and pharmaceutical industry, researching, developing, and producing plasma-derived medicines. These medicines treat rare, chronic diseases such as immune deficiencies and genetic emphysema. Grifols also provides hospital pharmacy products, diagnostic tools, and services for clinicians. Its key projects include the development of a potential treatment for Alzheimer's disease and producing a COVID-19 treatment using convalescent plasma. Grifols is committed to improving the health and well-being of people worldwide, and its innovative solutions continue to make it a leader in its industry.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 7,445.71 MM.
The operating income for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 1,489.28 MM.
The net income for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 297.45 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2025-06-30	7,445.71	1,489.28	297.45
2025-03-31	7,372.49	1,370.83	195.23
2024-12-31	7,212.38	1,319.52	156.92
2024-09-30	7,006.12	971.67	161.49
2024-06-30	6,810.64	1,008.00	148.68
2024-03-31	6,656.19	797.51	189.00
2023-12-31	6,591.98	961.07	42.32
2023-09-30	6,535.17	667.41	23.39
2023-06-30	6,478.82	753.57	-5.47
2023-03-31	6,358.26	568.16	46.70
2023-01-01	6,063.97	671.40	185.03
2022-09-30	5,549.47	593.76	149.16
2022-06-30	5,206.58	461.82	65.56
2022-03-31	5,015.58	520.75	112.10
2021-12-31	4,933.12	562.51	188.73
2021-09-30	5,044.20	753.97	360.63
2021-06-30	5,199.33	1,011.77	667.11
2021-03-31	5,231.45	906.92	562.10
2020-12-31	5,340.04	975.33	618.55
2020-09-30	5,391.62	1,013.85	687.43

Income Statement: EPS

The earnings per share basic for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.45.
The earnings per share diluted for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.45.

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2025-06-30	0.45	0.45
2025-03-31
2024-12-31	0.23	0.23
2024-09-30
2024-06-30	0.21	0.19
2024-03-31
2023-12-31	0.06	0.06
2023-09-30
2023-06-30	-0.01	0.01
2023-03-31
2023-01-01	0.27	0.27
2022-09-30
2022-06-30	0.10	0.10
2022-03-31
2021-12-31	0.28	0.28
2021-09-30	0.53	0.53
2021-06-30	0.97	0.97
2021-03-31	0.82	0.82
2020-12-31	0.90	0.90
2020-09-30	1.00	1.00

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 1,104.96 MM.
The cash from investing activities for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is -679.71 MM.
The cash from financing activities for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is -1,898.67 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2025-06-30	1,104.96	-679.71	-1,898.67
2025-03-31	1,202.56	777.27	-1,657.82
2024-12-31	902.17	886.67	-1,358.71
2024-09-30	527.03	921.12	-1,277.37
2024-06-30	386.99	1,001.43	182.45
2024-03-31	104.82	-402.55	322.49
2023-12-31	218.69	-394.72	171.49
2023-09-30	119.38	-399.77	341.79
2023-06-30	-122.76	-316.55	473.13
2023-03-31	-107.28	-1,880.62	-152.72
2023-01-01	-1.43	-1,996.12	-164.90
2022-09-30	50.49	-1,950.21	730.57
2022-06-30	289.20	-2,027.84	1,779.88
2022-03-31	454.26	-468.43	2,137.05
2021-12-31	596.98	-854.15	2,297.68
2021-09-30	726.79	-1,290.71	1,058.22
2021-06-30	908.93	-1,258.41	-90.87
2021-03-31	1,182.64	-1,311.77	-75.50
2020-12-31	1,110.34	-858.12	-354.40
2020-09-30	1,081.40	-461.80	-313.98

Valuation Metrics : PE, PriceToBook, PriceToTBV

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2023-01-01
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2023-01-01
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30

Management Effectiveness

The roa for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.01.
The roe for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.02.
The roic for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.01.
The croic for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.02.
The ocroic for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.06.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2025-06-30	0.01	0.02	0.01	0.02	0.06
2025-03-31	0.01	0.02	0.01	0.02	0.05
2024-12-31	0.01	0.02	0.01	0.01	0.03
2024-09-30	0.01	0.02	0.01	0.08	0.02
2024-06-30	0.01	0.02	0.01	0.00	0.01
2024-03-31	0.00	0.01	0.00	-0.00	0.01
2023-12-31	0.00	0.00	0.00	0.00	0.01
2023-09-30	0.00	0.00	0.00	-0.00	-0.01
2023-06-30	0.00	0.01	0.00	-0.00	-0.01
2023-03-31	0.01	0.03	0.00	-0.12	-0.01
2023-01-01	0.00	0.01	0.01	-0.06	0.00
2022-09-30	0.00	0.01	0.01	-0.06	0.00
2022-06-30	0.01	0.03	0.00	0.01	0.02
2022-03-31	0.01	0.03	0.01	0.12	0.03
2021-12-31	0.04	0.10	0.01	0.13	0.06
2021-09-30	0.02	0.09	0.02	0.03	0.06
2021-06-30	0.04	0.09	0.05	-0.04	0.07
2021-03-31	0.04	0.08	0.04	-0.02	0.08
2020-12-31	0.04	0.09	0.04	-0.01	0.08
2020-09-30	0.05	0.13	0.05	0.02	0.07

Gross Margins

The gross margin for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.39.
The net margin for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.03.
The operating margin for Grifols, S.A. - Depositary Receipt (Common Stock) as of June 30, 2025 is 0.19.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2025-06-30	0.39	0.03	0.19
2025-03-31	0.39	0.02	0.18
2024-12-31	0.39	0.02	0.14
2024-09-30	0.39	0.02	0.13
2024-06-30	0.39	0.03	0.12
2024-03-31	0.38	0.01	0.11
2023-12-31	0.37	0.00	0.10
2023-09-30	0.36	0.00	0.09
2023-06-30	0.36	0.00	0.09
2023-03-31	0.37	0.01	0.09
2023-01-01	0.37	0.03	0.11
2022-09-30	0.37	0.03	0.11
2022-06-30	0.75	0.01	0.09
2022-03-31	0.75	0.02	0.10
2021-12-31	0.45	0.04	0.12
2021-09-30	0.45	0.07	0.15
2021-06-30	0.45	0.13	0.19
2021-03-31	0.42	0.11	0.17
2020-12-31	0.42	0.12	0.19
2020-09-30	0.42	0.13	0.19